ArticleBMC cancer2013

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.

Yun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.